scorecardresearch
Add as a preferred source on Google
Thursday, October 9, 2025
TopicJohnson and Johnson

Topic: Johnson and Johnson

Rs 1 crore damages for ‘blatant infringement’: Johnson & Johnson’s big win in court against ORS copycats

New Delhi: The Delhi High Court has awarded damages of Rs 1.2 crore to multinational pharma company Johnson & Johnson in an infringement case...

Johnson & Johnson granted Rs 3.34 crore in damages by HC, what was the counterfeit products case

Offender was found to be a person, who ran a company by the name of Medserve. All seized counterfeit products can be destroyed by the healthcare giant, says HC.

Two doses of J&J’s vaccine slashes Omicron hospital stays in South Africa by up to 85%

The results are a welcome bit of news amid the explosive rise of Omicron cases and evidence that the strain can evade the protection that normally stems from vaccination.

Johnson & Johnson vaccine doesn’t provide antibody protection against Omicron, lab study finds

The J&J vaccine appears to provide some defense against Omicron, perhaps via other means such as stimulation of immune cells, according to a South African virologist.

US scientists suggest link between J&J vaccine and brain blood clots, but warn against panic

Researchers noted that the risk of blood clots should be considered in context of the vaccine’s efficacy, saying it is effective in offering protection from severe Covid-19.

Moderna, J&J boosters get US CDC’s backing, paving way for next shots

The CDC said eligible people may choose a different booster from the vaccine they originally received, granting more flexibility to patients and doctors.

US FDA clears Moderna, J&J booster shots, allows ‘mix and match’ of Covid vaccines

The Centers for Disease Control & Prevention will consult an expert panel later this week before finalising official recommendations for who should get boosters and when.

Johnson & Johnson seeks nod to conduct vaccine trails for 12-17 age group in India

Earlier in August, the US pharma giant Johnson & Johnson was given emergency use approval in India for its single-dose Covid-19 vaccine.

No clarity on India launch of single-dose J&J Covid jab as talks focus on indemnity hurdle

US pharmaceutical companies like Moderna, Pfizer and Johnson & Johnson have asked for indemnity against legal liability but the Government of India has not been inclined to give it.

J&J Covid vaccine gets emergency use nod in India. Here’s how the single-dose jab works

J&J became the fifth vaccine to get an emergency nod in the country, after Covishield, Covaxin, Sputnik V and Moderna.

On Camera

1948 need not define Gaza’s destiny. Arabs and Israelis must learn to live together

When Israelis pushed out Arabs in 1948, they didn’t think that embittered refugees would turn into a permanent threat to their new state. This was a catastrophic miscalculation.

60% increase in India’s carbon emissions by 2050, coal to remain top energy source: BP Energy Outlook

The country will account for 12 percent of global energy demand by 2050 from 7 percent in 2023, adds BP report.

ISKP & Lashkar converging under aegis of Pakistan’s ISI to take on Baloch fighters

ISKP, a sub-continental branch of the Islamic State, is said to have vowed to extend operations in Kashmir, on encouragement from Pakistan’s security establishment.

How Pakistan thinks: Army for hire, ideology of convenience

Pakistan’s army has been a rentier force available to a reasonable bidder. It has never come to the aid of any Muslims including Palestinians or the Gazans, except making noises here and there.